You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation

Article metrics

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation

 

Online download statistics by month:

Online download statistics by month: May 2021 to September 2025

AbstractFullPdf
May 2021388388167
Jun 202115815860
Jul 202113713752
Aug 202112212250
Sep 2021828254
Oct 2021727245
Nov 202110710848
Dec 20219810230
Jan 2022809343
Feb 2022798247
Mar 2022657329
Apr 2022677256
May 2022525370
Jun 2022626654
Jul 2022737560
Aug 2022858648
Sep 2022767881
Oct 2022788534
Nov 2022777836
Dec 2022555528
Jan 2023666632
Feb 202311511540
Mar 2023636541
Apr 2023484843
May 2023585832
Jun 2023333619
Jul 2023394130
Aug 2023384023
Sep 2023636427
Oct 2023464736
Nov 2023757542
Dec 2023454630
Jan 2024293321
Feb 2024383924
Mar 2024585851
Apr 2024666640
May 2024616151
Jun 2024686748
Jul 2024646530
Aug 2024454443
Sep 2024454534
Oct 20244546211
Nov 2024717237
Dec 2024818439
Jan 2025858528
Feb 2025727229
Mar 2025828263
Apr 2025919138
May 2025575731
Jun 2025555530
Jul 2025110
Sep 2025110
Total381738902335